UPDATE 1-J&J's Janssen hit with $70 mln verdict in Risperdal trial

NEW YORK, July 1 (Reuters) - A U.S. jury on Friday awarded

$70 million to the family of a boy who developed breasts after

taking Johnson & Johnson unit Janssen Pharmaceuticals'

antipsychotic drug Risperdal.

Read more